An observational study in Common Diseases and Rare Diseases, sponsored by Shandong University. Status unknown at 1 site in China. Per ClinicalTrials.gov, last updated 2022-11-10.
Sponsored by Shandong University · Observational
The purpose of this study is to form a chronological map of common diseases and rare diseases in Chinese population by determining the prevalence of different diseases in each age group.
Studying the distribution of various diseases in specific populations can help explore the causes of diseases, elucidate the distribution patterns, and develop preventive and control measures. Based on an overall assessment of prevalence, the combination of relevant results with age at diagnosis for multiple diseases is important for further understanding of the distribution of diseases at the population level. Therefore, this study aims to form a chronological map of common diseases and rare diseases in Chinese population by determining the prevalence of different diseases in each age group, thus providing a reference for more effective prevention, diagnosis and treatment of diseases.
203 studies on the registry are indexed under Rare Diseases; 112 are open to participants now.
This study's planned enrollment of 40,000,000 is above the median of 200 across 125 observational studies indexed under Rare Diseases.
Browse Rare Diseases studies →Shandong University is the lead sponsor of 284 studies on the registry; 59 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All inpatients within the period of January 1, 2017 to December 31, 2021.
Exclusion Criteria:
The diseases were included based on the results of the preliminary data exploration and standardization according to ICD-10.
Other: Data analysis
Data analysis is based on a single database from the National Health Medical Data (North Center).
age-specific prevalence rate
Age-specific prevalence rate stratified by sex were calculated by dividing the number of incident cases with a current disease by the total number of people in the study population during that time period.
Time frame: between January 1, 2017 and December 31, 2021
sex-specific prevalence rate
Sex-specific prevalence rate stratified by age for 10-year bands were calculated by dividing the number of incident cases with a current disease by the total number of people in the study population during that time period.
Time frame: between January 1, 2017 and December 31, 2021
total cost of hospitalization
Total cost of hospitalization and deductibles for the total population and for each age group of diseases are described by mean (SD) values.
Time frame: between January 1, 2017 and December 31, 2021
This study is status unknown, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Shandong University